370 likes | 410 Views
Shock. Sarah Leyland Practice Educator – General ICU. Learning Outcomes. Review shock at a cellular level Discuss categories of shock Describe clinical features of the different types of shock Identify management strategies for shock. Shock. Shock is “circulatory insufficiency”
E N D
Shock Sarah Leyland Practice Educator – General ICU
Learning Outcomes • Review shock at a cellular level • Discuss categories of shock • Describe clinical features of the different types of shock • Identify management strategies for shock
Shock • Shock is “circulatory insufficiency” • Often goes unrecognised in its early stages • Shock is never the primary diagnosis • Reflects the bodies attempts to preserve vital functions
Shock definition “Failure to deliver and / or utilise adequate amounts of oxygen leading to tissue dysoxia” Antonelli et al (2007) Intensive care medicine 33, 575-590 • n.b definition does not include hypotension (but this is usually present). • If hypotension absent markers include ScvO2, SvO2, base deficit, lactate, perfusion related low pH
Shock at a cellular level • Hypoxaemia or perfusion failure result in anaerobic metabolism =2 ATP molecules, (aerobic=36 ATP molecule) • Na-K pumps fail, ( K, Na and water enter cell) (Darovic 2002)
Capillary function • Swollen cells reduce capillary lumen diameter, reducing blood flow • Clumping of blood cells plugs capillaries • Cell junctions between cells widen allowing leaking • Unstable cellular environment > lysosomes release (Darovic 2002)
Organ systems • Depending on number of cells lost organ damage may occur • Persons response to shock depends on pre- existing disease, drug use, age, magnitude if illness and time period of development of shock (Darovic 2002)
Stage 1 –Compensated (Initial) • A fall in BP is detected this causes the release of adrenaline and noradrenaline that increase heart rate, contractility and vasoconstrict blood vessels. • BP may be normal, but heart rate is increased, urine output decreased, patient may be cool to touch and restless
Stage 2 – Decompensated (Progessive) • BP falls, cerebral and myocardial hypoperfusion result in deteriorating mental status, myocardial ischaemia and absent peripheral pulses • Stress response causes vasoconstriction - waxy, pale, cold, clammy skin. Pale mucous membranes and nail beds, low UO
Stage 3 – Irreversible (Refractory) • All major organ systems are affected • Systemic hypoperfusion will ultimately become incompatible with life (Darovic 2002)
“Double Edged Sword” of compensation in shock • Darovic (1995p. 448) • Systemic vasoconstriction maintains blood flow to vital organs • Inflammatory mediator release facilitates phagocytosis and resolution of injury • But: • Less essential circulations sacrifices:massive tissue ischaemia and lactic acidosis • Prolonged or overwhelming mediator release leads to SIRS and multiple organ failure.
What is blood pressure made of? • CO (= HR x SV) • SVR • Contractility
Categories: • Cardiogenic shock • Hypovolaemic shock • Distributive shock : - Septic shock - Neurogenic shock - Anaphylactic shock. More than one type of shock can exist in an individual.
Cardiogenic Shock • The most common cause is MI • What is the spiral of events that follows a drop in blood pressure?
Hypovolaemic shock • This is a reduction in the circulating volume leading to decreased venous return and cardiac output
Sepsis: • Pathophysiology related to mediator and neuro endocrine repsonse: • Maldistribution of circulating blood volume • Imbalance of oxygen supply and demand • Alterations of metabolism
Definitions – Changed in 2016 Seymour et al (2016) Singer et al (2016) Sepsis – “life threatening organ dysfunction caused by disregulated host response to infection” (Singer et al 2016) Organ dysfunction = change in SOFA score (Seymour et al 2016) Septic Shock = subset of sepsis in which profound circulatory, cellular and metabolic abnormalities are assoc. with a greater risk of mortality than sepsis alone (Singer et al 2016)
Anaphylactic shock • An exaggerated systemic allergic reaction to an antigen • The antigen-antibody or substances such as contrast media cause release of mediator substances. This causes ‘leaky capillaries’ and generalised swelling and acute pulmonary oedema. • Arteries dilate causing hypotension • Smooth muscle contraction can cause bronchospasm
Neurogenic Shock • May be produced by spinal cord damage or pharmacological blockade at T6 or above • Brain stem messages to the peripheral nerves to maintain vasoconstriction and cardioaccelerator reflexes are interrupted. • This may cause hypotension and bradycardia
ESCIM (2014) • Three ‘windows’ through which to view signs of hypoperfusion: • Peripheral – skin that is cold, clammy and blue ,pale or discoloured • Renal - urine output < 0.5 ml/kg/hour • Neurologic – obtundation, confusion • Low BP may not be present
Patient Assessment • Consciousness level / Mentation reports of pain • Blood pressure • Heart rate / Pulses • Respiratory system • Cutaneous • Urine output • Invasive haemodynamic monitoring – needs to be PAC if severe, need dynamic assessment of fluid status
General Principles of Treatment • Correct the primary cause. • Ensure adequate airway, ventilation, and arterial oxygenation • Fluid resuscitation ? (Probably crystalloids) • Followed by vasoactive drugs • ESCIM (2014) – targets for BP initially Map> 65mmHg……. But alterations if haemorrhage and also for sepsis in known hypertensive patient
Most important inotrope? • Fluid! • Fluid challenge should be given over 5-10 mins • Assessment before and after to see where you are on Starling curve • If SV rises 10% or more you are on the up slope and more fluid can be given to good effect • If you give inotropes or vasopressors to an under-filled patient, side effects and mortality worsen
Inotropes and Vasopressors • Correct terminology seldom used • Vasopressor – causing vasoconstriction • Inotrope – increasing contractility • Chronotrope – increasing heart rate • Inodilator – inotrope and vasodilator
Commonly seen in ICU • Noradrenaline – vasopressor • Vasopressin – vasopressor (consultant direction only G ICU) • Dobutamine – inodilator • Milrinone – inodilator • Dopamine – inotrope (& vasopressor) • Dopexamine – mild inotrope and selective (gut & mesentery) dilator • Adrenaline – inotrope, vasopressor and chronotrope
Hypovolaemia - management • Hypovolaemia – aim is to stop fluid loss and restore blood volume - fluid challenges. • Note massive haemorrhage protocol (new Nov 2015) • Ensure adequate ventilation and oxygenation. • N.B care required with opiates (inhibit arteriolar constriction)
Cardiogenic shock • Cardiogenic shock – systolic BP< 90mmHg for at least 30 mins, CI <2.2l/min/m2, PAOP >15mmHg • Investigations – ECG, Bloods (inc. novel trial device) • Interventions include: Thrombolysis, angiography, PCI, CABG may be required for re perfusion • Analgesia – Morphine < sympathetic response and < diaphoresis • Control rhythm disturbances • Pharmocological adjustment to SVR
Neurogenic shock - management • Continuous ECG monitoring • Atropine may be required if Heart rate <50 and systolic BP<80. • This type of shock MUST be distinguished from hypovolaemia • Aggressive fluid therapy may precipitate pulmonary oedema in neurogenic shock. • Vasopressors may also be required. • Careful monitoring is needed – signs of abdominal trauma may be missed due to flaccid abdominal wall in tetraplegic patients. (Adam and Osborne 2005)
‘Survive Sepsis’ • UK initiative – education programme • The Sepsis Six • High flow oxygen • Take blood cultures • Give IV antibiotics • Start IV fluid resuscitation • Check lactate • Monitor hourly urine output • All to be completed within 1 hour of suspected sepsis diagnosis
What next? • Revision of sepsis bundles 2016 • References: • Adam S & Osborne S (2005) Critical Care Nursing; science and practice (2nd Ed). Oxford: Oxford Medical Publications. • Cecconi et al (2014) Consensus on circulatory shock and haemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Int Care Med. 40 1795-1815 • Darovic G (2002) Haemodynamic Monitoring:invasive and noninvasive clinical application. Saunders. Philadelphia • Dellinger et al (2012) International guidelines • for the management of severe sepsis and septic shock Int Care Med. • www.resus.org.uk anaphylaxis algorithm • Seymour et al (2016)Assessment of clinical criteria for sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis -3). JAMA 315 (8) p. 762-774 • Singer et al (2016) The third International Consensus Definitions for sepsis and Septic Shock (Sepsis -3) JAMA 315(8) p. 801-810